Pediatrix Medical Group Appoints New CEO Mark S. Ordan, Updates 2024 Adjusted EBITDA GuidanceOn January 13, 2025, Pediatrix Medical Group, Inc. (NYSE: MD) announced in an 8-K filing a significant leadership transition aimed at enhancing shareholder v

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Pediatrix Medical Group’s 8K filing here.

Pediatrix Medical Group Company Profile

(Get Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Stories